ScienceDex / Researcher record
Boss, Olivier
- Energesis Pharmaceuticals, Inc. (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2013 | $168,876 | 1 | #33,137 |
| 2014 | $276,203 | 1 | #27,488 |
| 2016 | $812,187 | 1 | #8,890 |
| 2017 | $1,763,290 | 2 | #3,222 |
| 2018 | $981,584 | 1 | #7,757 |
| 2021 | $1,018,644 | 1 | #9,000 |
| 2022 | $969,884 | 1 | #10,230 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20131 record
- FY20141 record
- FY20161 record
- FY2017 · selected2 records
- FY20181 record
- FY20211 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Boss, Olivier as a PI. Multi-PI records show the full award amount for context.
- 5R44DK109860-02R44Contact PIEstablishing In Vivo Proof of Concept of Brown Adipogenesis Using Approved Drugs$969.3Kaward amount
- 1R44DK113877-01A1R44Contact PIOptimization and Pre-Clinical Studies of a Protein Therapeutic for Recruiting Brown Adipocytes$794Kaward amount
Award organization
Organizations that administered FY2017 awards listing Boss, Olivier as a PI.
FY2017 award administered by Energesis Pharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardEnergesis Pharmaceuticals, Inc.
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #8890
- 2017$2M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #3222
- 2021$5M Cumulative Funding